The Psychology of Health

Chatbots and large language models are becoming increasingly common in everyday life, but their growing presence in healthcare has raised an important question: Should probabilistic AI systems be used to help make medical decisions? This episode takes a clear, grounded look at why the answer is far more complicated—and potentially far more dangerous—than many people realize.Modern chatbots work by predicting the most statistically likely response based on patterns found in massive amounts of text. That makes them great for conversation, brainstorming, and general information, but not for something as complex and high‑stakes as medical diagnosis. In clinical settings, symptoms like persistent cough and chest pain can point to a wide range of possible conditions. A probabilistic model might default to the most common explanation, but medicine doesn’t work on majority statistics—it works on understanding nuance, context, risk, and rare but critical exceptions.This episode explores how relying on “most likely” answers can lead to missed diagnoses, delayed treatments, and dangerous oversights. You’ll hear how serious conditions such as pulmonary embolism or early lung cancer can present with the same symptoms as common respiratory infections, making a simplistic, probability‑driven guess both insufficient and unsafe. We also dive into the accuracy paradox—how an AI system can appear highly accurate while still being clinically untrustworthy, simply because it always chooses the dominant category.Beyond the risks, this episode highlights what real medical reasoning involves: integrating visual cues, patient history, audio signals, imaging studies, laboratory data, physiological waveforms, and much more. Human clinicians synthesize all these inputs at once, something a probabilistic chatbot was never designed to do. By understanding this difference, listeners will gain a deeper appreciation for the limitations of current AI tools and why responsible, deterministic models are essential in healthcare.Whether you’re a clinician, medical student, AI researcher, or simply curious about how technology intersects with patient care, this episode offers a clear and accessible exploration of why chatbots, despite their impressive capabilities, should not be mistaken for diagnostic tools.

Another week, another headline declaring AI has officially surpassed physicians. This time, it's a study published in Science on April 30, 2026, claiming that OpenAI's o1 model "outperformed physician baselines" across multiple diagnostic reasoning tasks. The research comes from Harvard, Stanford, and Beth Israel Deaconess Medical Center. It's rigorous. It's peer-reviewed. And it's already being cited as proof that doctors are obsolete.But here's what those viral headlines won't tell you: the study tested AI on text alone.No images. No audio. No physical exams. No watching a patient walk through the door in distress before they utter a single word. No recognizing the subtle facial asymmetry that suggests stroke. No hearing the quality of a cough. No feeling a mass during examination. No interpreting the fear in a patient's eyes.In other words—not real medicine.In this episode, we unpack why this study, despite its methodological rigor, may be doing more harm than good. We explore the "headline-to-reality pipeline"—how clickbait economics strips away the authors' own caveats until all that remains is a misleading soundbite. We discuss the real-world consequences: misinformed patients with unrealistic expectations, demoralized clinicians, misallocated healthcare resources, and a generation of medical trainees learning exactly the wrong lessons about AI.Perhaps most critically, we address the "chatbot conflation problem." When the public hears "AI in medicine," they picture ChatGPT. But as of late 2025, over 850 AI-enabled medical devices have received FDA clearance—more than 70% related to medical imaging. These task-specific systems detecting pulmonary nodules, identifying intracranial hemorrhages, and flagging diabetic retinopathy are fundamentally different from large language models answering text prompts. Different architecture. Different validation. Different regulatory pathways. Different levels of evidence. Lumping them together under "AI" does a disservice to both.We also tackle a question the headlines never ask: What would a fair evaluation of AI in medicine actually look like? Hint—it would require multimodal inputs, messy real-world data, and a fundamentally different benchmark: not "Can AI beat doctors?" but "Do doctors WITH AI outperform doctors WITHOUT AI?"Finally, we make the case for why medical education must lead this conversation. If we don't teach our students—and frankly, the broader public—the critical distinctions between AI tools, what happens? Clinicians lose trust not just in overhyped chatbots, but in all medical AI, including the FDA-cleared tools actually saving lives. That erosion of trust could take a generation to repair.The technical findings of this study may be sound. But science doesn't exist in a vacuum. It exists in a media ecosystem that rewards sensationalism, in a healthcare system desperate for solutions, and in a culture increasingly willing to believe AI can do anything. The responsible approach is to be louder about limitations than findings.Because right now, we're celebrating an AI that aced a written exam—while the actual test, the messy, multimodal, deeply human reality of clinical medicine, remains completely ungraded.What You'll Learn: • Why text-based AI evaluations fundamentally misrepresent clinical medicine • The critical distinction between task-specific medical AI and general chatbots • How clickbait economics transforms nuanced research into dangerous misinformation • What fair AI evaluation in healthcare would actually require • Why medical educators must lead the conversation on AI literacyResources Mentioned: • Brodeur PG, et al. "Performance of a large language model on the reasoning tasks of a physician." Science. 2026;392(6797):524-527 • FDA AI-Enabled Medical Device Database • Clinical AI Course (NYIT College of Osteopathic Medicine)

Artificial intelligence is rapidly moving into classrooms, clinics, and daily healthcare decision making, but much of the public conversation is built on a dangerous misunderstanding. Too often, people now treat artificial intelligence as if it simply means chatbots. In this episode, Dr. Milan Toma explains why that confusion matters and why healthcare professionals must learn to distinguish between conversational tools and task specific medical systems.This episode explores the long history of artificial intelligence in medicine, why chatbots are optimized for fluent language rather than true clinical understanding, and why strong performance on text based clinical vignettes should not be mistaken for real world diagnostic ability. Dr. Toma also examines the risks of artificial intelligence sycophancy, the danger of overfitting, the limits of accuracy as a metric, and how data leakage or hidden shortcuts can make weak systems look impressive during development.Most importantly, this is a conversation about education and patient safety. Healthcare professionals need more than basic exposure to artificial intelligence tools. They need to understand how different systems work, how they fail, how to evaluate claims critically, and why clinicians must work closely with developers before these tools are trusted in practice.The goal is not simply to teach people how to use artificial intelligence. It is to teach them how to question it, evaluate it, and apply it responsibly. The future of healthcare will include artificial intelligence, but safe healthcare depends on how well we teach people to understand it.

Introduction: A Tale of Two RoundsEvery attending physician has seen the "Star Student" who can quote the New England Journal of Medicine verbatim but freezes when a patient doesn't follow the script. In this episode, we introduce Student A and Student B.Student A (The Memorizer): They have a mental database of every practice vignette. They are fast, confident, and statistically "perfect" on paper.Student B (The Thinker): They are slower. They visualize the blood flow, the cellular response, and the "why" behind the symptoms.We discuss why the current "Gold Rush" of Medical AI is accidentally scaling Student A to an industrial level, creating systems that look like geniuses in a lab but perform like novices in a clinic.In machine learning, overfitting is the statistical equivalent of "rote memorization." We break down the mechanics of how a model loses the forest for the trees.How do you "interview" an AI to see if it actually knows its stuff? You look at its Learning Curves. We explain how to read these graphs like a clinical EKG.The Divergence Warning: When training accuracy rockets to 100% while validation accuracy (the "real world" test) plateaus or drops, you aren't looking at a breakthrough; you’re looking at a memory bank.The Convergence Goal: A healthy model shows two lines that "hug" each other as they rise. This signifies that what the model learns in the "textbook" is actually applying to the "patient."Why do models overfit? Often, it’s because they found a shortcut. We explore the "Red Flags" that developers—and clinicians—need to watch for:Spurious Correlations: The model learns that "Patients with X-rays taken on a portable machine are sicker," rather than learning what is in the X-ray.Data Leakage: Including variables that already "hint" at the answer (e.g., predicting a condition using the medication used to treat it).Institutional Bias: Memorizing how one specific hospital operates rather than how a disease operates.We tackle the most dangerous metric in healthcare: Raw Accuracy. > "If 95% of your patients are healthy, a model can be 95% accurate by simply predicting 'Healthy' for every person it sees. It has a 0% success rate at finding disease, yet it gets a 95% grade. This isn't just bad math—it's dangerous medicine."We discuss why Sensitivity and Specificity are the only metrics that truly matter in a clinical setting.How do we build "Student B" AI? It requires a fundamental shift in development:External Validation: Testing the model on data from a completely different hospital or geographic region.Patient-Level Splits: Ensuring the model never sees the same patient in training and testing.Clinician-in-the-Loop: Why doctors must be involved in feature selection to spot "leaky" data that a data scientist might miss.We wrap up the episode with a practical toolkit. Before you trust an AI system with your family, ask the developers these five questions:Was data split at the patient level? (Did you prevent the model from memorizing specific individuals?)Were leaky features identified and removed? (Is the model cheating using "proxy" data?)What do the training curves show? (Can I see the "EKG" of how this model learned?)How was class imbalance handled? (What is your Sensitivity for the actual disease cases?)Was there external validation? (Has this worked at a hospital that isn't yours?)Real medicine is messy. It’s atypical symptoms, patients with five comorbidities, and "unusual" presentations. If we want AI to be a partner in the clinic, we need it to be a "Student B." We need it to understand the pathophysiology of the data, not just the answers on the test.Join us as we move past the hype and toward a future of robust, reliable, and truly intelligent medical AI.Based on the work and research of Dr. Milan Toma and synthesized from over 40 peer-reviewed studies on clinical AI evaluation.

Have you ever wondered why skepticism about artificial intelligence persists in healthcare, even as new AI tools are rapidly introduced? In this episode, Dr. Milan Toma, Associate Professor of Clinical Sciences at NYIT College of Osteopathic Medicine, explains the roots of distrust in clinical AI systems and what it takes to regain confidence. Drawing on decades of machine learning evolution, real-world case studies, and his own research experience, Dr. Toma discusses the dangers of overfitting, the importance of healthy training dynamics, and the vital role of collaboration between clinicians and developers. Tune in to learn how the healthcare community can move from skepticism to trust and ensure that AI serves the needs of both patients and professionals.

Imagine you are developing an AI system to predict which patients are at risk of becoming obese based on their lifestyle factors. You gather data on diet, exercise habits, sleep patterns, stress levels, and dozens of other variables. You train your model. It achieves 99% accuracy. You celebrate.Then someone points out that you included the patients' current weight in your dataset.Your model did not learn anything about lifestyle risk factors. It learned to calculate BMI. It took a shortcut. And that shortcut rendered your entire effort clinically useless.This is the problem of algorithmic shortcuts in medical AI, and it is flooding our research literature with impressive-looking results that will crumble the moment they encounter real patients.Machine learning models are optimization engines. They will find the easiest path to high accuracy, whether or not that path has any clinical meaning. When your training data contains features that essentially give away the answer, the model will exploit them ruthlessly.This is not a bug. It is exactly what the algorithm is designed to do. The problem is that we, the humans, failed to recognize that we handed the model an answer key along with the exam.Consider what happens when you include a "diabetes medication" column in a model designed to predict diabetes. The model quickly learns: if this column says "metformin," predict diabetes. It achieves near-perfect accuracy. But it has learned nothing useful. If you already know the patient is on diabetes medication, you do not need AI to tell you they have diabetes. You need AI to identify patients before they develop the condition, when intervention can still make a difference.This is the fundamental paradox: the features that make prediction easiest are often the features that make prediction pointless.

When a ninety nine percent accurate AI misses every single case of disease, something has gone terribly wrong.In this episode, Dr. Milan Toma exposes one of the most dangerous pitfalls in medical artificial intelligence: the accuracy paradox. Discover why impressive accuracy numbers can mask complete clinical failure, and why that four percent drop in accuracy might actually save lives.Dr. Toma explains how the fundamental nature of medical data, where the healthy are many and the sick are few, creates conditions where a system can achieve near perfect accuracy while detecting absolutely nothing. He walks through the math, the real world consequences, and the alternative metrics that actually matter for patient care.In this episode you will learn:Why a trivial classifier predicting everyone healthy achieves ninety nine percent accuracy while catching zero disease cases. How conditions like atrial fibrillation, breast cancer, and malignant arrhythmias create severely imbalanced datasets. The cascade of harm that unfolds when AI systems miss diagnoses, from false reassurance through disease progression to preventable patient harm. Why false negatives in medicine carry consequences far exceeding false positives. Which metrics, including sensitivity, specificity, F1 score, Matthews Correlation Coefficient, and balanced accuracy, reveal what accuracy hides. What clinicians, developers, and patients should demand from medical AI before trusting it with diagnosis.Presented by: Dr. Milan Toma, PhD, SMIEEE Associate Professor of Clinical Sciences College of Osteopathic Medicine New York Institute of TechnologyFor deeper exploration: Diagnosing AI: Evaluation of AI in Clinical Practice (2026)

What can a 2017 colonoscopy study teach us about using AI diagnostics safely in 2025?An AI diagnostic tool boasts 99% accuracy. Should you trust it? In this episode, I explain why that number can be dangerously misleading and equip medical professionals with the practical strategies needed to see through the hype and protect their patients.As artificial intelligence becomes more integrated into healthcare, the ability to critically evaluate these tools is no longer optional; it's a core clinical skill. This session moves beyond the headlines to uncover the common, often hidden, flaws in AI training that can lead to inflated performance metrics and real-world risk. Learn how to become the essential human-in-the-loop who can distinguish a robust, reliable AI from a brittle and dangerous one.In this video, you will learn:The "Memorizing Student" Problem: A simple analogy to understand Overfitting, one of the most common ways AI models fail in the real world.How to Spot the Flaws: Practical techniques to diagnose unreliable AI, including how to interpret learning curves and why true external validation is the gold standard.The Danger of "Cherry-Picking": How selective reporting creates a false perception of reliability and why demanding transparency is crucial.The Colonoscopy Analogy: A powerful, real-world framework for how clinicians should approach AI results right now. Learn how to use a "positive" AI signal to your advantage and, more importantly, how to handle a "negative" signal to prevent catastrophic errors from automation bias.Your Ultimate Responsibility: Why the physician, not the algorithm, is always accountable and how to use AI as a tool for support, not an absolution of your clinical judgment.If you are a physician, medical student, resident, or healthcare administrator, this presentation provides the foundational knowledge you need to navigate the next wave of medical technology safely and effectively.

Are we caught in another tech hype cycle with AI? The promise of technology often clashes with financial and practical reality. This presentation cuts through the noise to offer a clear and balanced framework for thinking about the future of artificial intelligence in business and society.Join me for a thoughtful exploration of how to navigate the booms and busts of innovation. Using the "Could, Should, Might, and Don't" mindsets developed by futures designer Nick Foster, this talk dissects the different ways we approach the future—from the exciting, sci-fi visions of "Could Futurism" to the critical, ethical questions of "Don't Futurism."In this video, you will learn:How to recognize the phases of a technology hype cycle and avoid common pitfalls.The four key mindsets for engaging with the future of AI.Why user-centric design and adaptability are crucial for successful innovation, learning from past tech implementations.The importance of balancing optimism with a healthy dose of skepticism and ethical consideration.What are your thoughts on the future of AI? Which mindset—Could, Should, Might, or Don't—resonates most with you?

This episode provides an overview of Total Energy Expenditure (TEE) and Basal Energy Expenditure (BEE), emphasizing their definitions, measurement methods, and patterns across the human lifespan. It explains that TEE is the total of all calories burned, comprised mainly of BEE (the energy needed for basic functions at rest), the Thermic Effect of Food, and Physical Activity Energy Expenditure. Contrary to common beliefs, I explain that metabolism remains stable from ages 20 to 60, and midlife weight gain is primarily linked to lifestyle shifts rather than a sudden slowdown. The episode stresses the importance of objective measurement techniques, such as doubly labeled water for TEE, and highlights that body composition, particularly lean mass, is the main determinant of BEE. Finally, it corrects misconceptions regarding the impact of exercise and notes that metabolism declines gradually only after age 60, largely due to loss of lean tissue.Sources:Herman Pontzer, Yosuke Yamada, Hiroyuki Sagayama, Philip N. Ainslie, Lene F. Andersen, Liam J. Anderson, Lenore Arab, Issaad Baddou, Kweku Bedu-Addo, Ellen E. Blaak, Stephane Blanc, Alberto G. Bonomi, Carlijn V.C. Bouten, Pascal Bovet, Maciej S. Buchowski, Nancy F. Butte, Stefan G. Camps, Graeme L. Close, Jamie A. Cooper, Richard Cooper, et al. Daily energy expenditure through the human life course. Science, 373(6556):808–812, 2021. doi:10.1126/science. abe5017.Kay Nguo, Helen Truby, and Judi Porter. Total energy expenditure in healthy ambulatory older adults aged ≥80 years: A doubly labelled water study. Annals of Nutrition and Metabolism, 79(2):263–273, 2023. doi:10.1159/000528872.John R. Speakman, Jasper M. A. de Jong, Srishti Sinha, Klaas R. Westerterp, Yosuke Yamada, et al. Total daily energy expenditure has declined over the last 3 decades due to declining basal expenditure not reduced activity expenditure. Nature Metabolism, 5(4):579–588, 2023. doi:10.1038/s42255-023-00782-2.Marie-Pierre St-Onge and Dympna Gallagher. Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation? Nutrition, 26(2):152–155, February 2010. doi:10.1016/j.nut.2009.07.004.

This episode challenges the common belief that weight gain in middle age is caused by a slowing metabolism, asserting that adult metabolism generally remains stable until after age sixty. Instead, it explains that weight gain is primarily driven by lifestyle factors, such as reduced physical activity and increased caloric intake. It details how the body mounts a powerful biological defense against weight loss, interpreting caloric restriction as a threat and triggering adaptive thermogenesis, which suppresses metabolism and increases hunger. Consequently, repeated cycles of weight loss and regain, known as weight cycling, become progressively more difficult and may disrupt metabolic health. The episode concludes that the most effective strategy for lifelong weight management is preventing weight gain through consistent lifestyle adjustments rather than relying on restrictive dieting after weight has accumulated.Sources:Herman Pontzer, Yosuke Yamada, Hiroyuki Sagayama, Philip N. Ainslie, Lene F. Andersen, Liam J. Anderson, Lenore Arab, Issaad Baddou, Kweku Bedu-Addo, Ellen E. Blaak, Stephane Blanc, Alberto G. Bonomi, Carlijn V.C. Bouten, Pascal Bovet, Maciej S. Buchowski, Nancy F. Butte, Stefan G. Camps, Graeme L. Close, Jamie A. Cooper, Richard Cooper, et al. Daily energy expenditure through the human life course. Science, 373(6556):808–812, 2021. doi:10.1126/science. abe5017.Allyson K. Palmer and Michael D. Jensen. Metabolic changes in aging humans: current evidence and therapeutic strategies. The Journal of Clinical Investigation, 132(16):e158451, 2022. doi:10.1172/JCI158451.Xiaotao Shen, Chuchu Wang, Xin Zhou, Wenyu Zhou, Daniel Hornburg, Si Wu, and Michael P. Snyder. Nonlinear dynamics of multi-omics profiles during human aging. Nature Aging, 4:1619–1634, 2024. doi:10.1038/s43587-024-00692-2.Paul S. MacLean, Audrey Bergouignan, Marc-Andre Cornier, and Matthew R. Jackman. Biology’s response to dieting: the impetus for weight regain. Amer- ican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 301(3):R581–R600, September 2011. doi:10.1152/ajpregu.00755.2010.

This episode fundamentally challenges the popular belief that human metabolism slows down during midlife, asserting instead that total energy expenditure remains stable between the ages of 20 and 60, only declining after age 60. Using gold-standard measurements, the text explains that the weight gain many adults experience is not due to a slowing metabolism but rather to changes in body composition, specifically the loss of lean muscle mass and the accumulation of fat. Furthermore, this episode highlights that aging and metabolic decline occur nonlinearly, with major molecular and functional transitions occurring around ages 44 and 60, which correspond to accelerated risks for age-related diseases. Consequently, this episode suggests that effective weight management strategies must focus on preserving muscle mass, promoting physical activity, and timing interventions to align with these critical metabolic inflection points.Based on:Herman Pontzer, Yosuke Yamada, Hiroyuki Sagayama, Philip N. Ainslie, Lene F. Andersen, Liam J. Anderson, Lenore Arab, Issaad Baddou, Kweku Bedu-Addo, Ellen E. Blaak, Stephane Blanc, Alberto G. Bonomi, Carlijn V.C. Bouten, Pascal Bovet, Maciej S. Buchowski, Nancy F. Butte, Stefan G. Camps, Graeme L. Close, Jamie A. Cooper, Richard Cooper, et al. Daily energy expenditure through the human life course. Science, 373(6556):808–812, 2021. doi:10.1126/science. abe5017.Allyson K. Palmer and Michael D. Jensen. Metabolic changes in aging humans: current evidence and therapeutic strategies. The Journal of Clinical Investigation, 132(16):e158451, 2022. doi:10.1172/JCI158451.Xiaotao Shen, Chuchu Wang, Xin Zhou, Wenyu Zhou, Daniel Hornburg, Si Wu, and Michael P. Snyder. Nonlinear dynamics of multi-omics profiles during human aging. Nature Aging, 4:1619–1634, 2024. doi:10.1038/s43587-024-00692-2.

This episode provides an overview of the significant challenge of dietary underreporting bias in nutrition research, especially concerning individuals with obesity. It explains how some people with higher body mass index (BMI) systematically and substantially under-report their true food and calorie consumption, often by 700 to 850 kcal per day, which is far more than their lean counterparts. The episode highlights that doubly labeled water (DLW) is the objective "gold standard" method for measuring actual calorie expenditure, and studies using DLW consistently validate the extent of this underreporting. This systematic inaccuracy, often driven by factors like social desirability bias, renders self-reported data from national surveys like NHANES largely unreliable for accurately assessing true calorie intake or its link to obesity trends. Ultimately, the episode cautions researchers to use objective measures and not rely solely on self-reported data when studying obesity.Source on which the episode is based:

This episode provides an extensive critique of the reliability of self-reported dietary surveillance data, arguing that simple correlations between dietary trends (like increased calories or changes in macronutrients) and the rise in U.S. obesity rates are misleading. The episode emphasizes that correlation does not equal causation and highlights the significant problem of systematic underreporting of calorie intake, particularly among individuals with higher body mass index. Furthermore, I assert that observed increases in reported calorie intake over time may actually reflect changes in survey methodology rather than real shifts in eating behavior. Finally, I note that despite increasing use of dietary supplements, most Americans still fail to meet recommended intakes for several key micronutrients, underscoring that overall dietary quality remains suboptimal.The studies on which this episode was based:Chery lD. Fryar, Jacqueline D. Wright, Mark S. Eberhardt, and Bruce A. Dye. Trends in nutrient intakes and chronic health conditions among mexican-american adults, a 25-year profile: United states, 1982–2006. Technical Report 50, National Center for Health Statistics, Hyattsville, MD, 2012. URL: https://www.cdc.gov/nchs/data/nhsr/nhsr050.pdf.Edward Archer, Gregory A. Hand, and Steven N. Blair. Validity of u.s. nutritional surveillance: National health and nutrition examination survey caloric energy intake data, 1971–2010. PLoS ONE, 8(10):e76632, 2013. doi:10.1371/journal.pone.0076632.Marjorie R. Freedman, Victor L. Fulgoni, and Harris R. Lieberman. Temporal changes in micronutrient intake among united states adults, NHANES 2003 through 2018: A cross-sectional study. The American Journal of Clinical Nutrition, 119(6):1309–1320, 2024. doi:10.1016/j.ajcnut.2024.02.007.Alexandra E. Cowan, Janet A. Tooze, Jaime J. Gahche, Heather A. Eicher-Miller, Patricia M. Guenther, Johanna T. Dwyer, Nancy Potischman, Anindya Bhadra, Raymond J. Carroll, and Regan L. Bailey. Trends in overall and micronutrient-containing dietary supplement use in us adults and children, NHANES 2007–2018. The Journal of Nutrition, 152(12):2789– 2801, 2022. doi:10.1093/jn/nxac168.

This episode provides an extensive overview of the complex biological regulation of appetite and energy balance, moving beyond the simple "calories in, calories out" model. It establishes that fat tissue is an active endocrine organ that produces hormones crucial for signaling the brain about the body's energy status. The episode highlights the central role of the hormone leptin, explaining that it suppresses hunger when fat stores are adequate and drives eating when stores are low. I contrast leptin deficiency, which causes unrelenting hunger and metabolic disease that is treatable with hormone replacement, with the more common condition of leptin resistance seen in obesity, where the brain fails to respond to high leptin levels, thereby promoting continued hunger and weight gain. Ultimately, this episode argues that appetite and weight regulation are governed by hormonal feedback systems that often override conscious control, underscoring the biological challenge of managing weight.Studies on which this episode was based:Dr. Shilpa Balaji Asegaonkar. Insights into role of adipose tissue as endocrine organ. International Journal of Diabetes Research, 1(1):01–04, January 2019. doi:10.33545/26648822.2019.v1.i1a.1.Alexandros Vegiopoulos, Maria Rohm, and Stephan Herzig. Adipose tissue: between the extremes. The EMBO Journal, 36(14):1999–2017, June 2017. doi:10.15252/embj.201696206.F. Lonnqvist. The obese (OB) gene and its product leptin–a new route toward obesity treatment in man? QJM, 89(5):327–332, May 1996. doi: 10.1093/qjmed/89.5.327.Julie A. Chowen and Jesu ́s Argente. Leptin and the brain. HMBCI, 7(2):351–360, August 2011. doi:10.1515/hmbci.2011.113.Jeffrey S Flier and Eleftheria Maratos-Flier. Obesity and the hypothalamus: Novel peptides for new pathways. Cell, 92(4):437–440, February 1998. doi:10.1016/s0092- 8674(00)80937- x.Milen Hristov. Leptin signaling in the hypothalamus: Cellular insights and therapeutic perspectives in obesity. Endocrines, 6(3):42, August 2025. doi:10.3390/endocrines6030042.Jiarui Liu, Futing Lai, Yujia Hou, and Ruimao Zheng. Leptin signaling and leptin resistance. Medical Review, 2(4):363–384, August 2022. doi: 10.1515/mr-2022- 0017.

This episode provides an extensive overview of the strong relationship between insufficient sleep and the increased risk of weight gain and metabolic dysfunction. It emphasizes that epidemiological data consistently identify short sleep duration as an independent risk factor for obesity, particularly in younger populations. Mechanistically, sleep deprivation is shown to disrupt appetite-regulating hormones, specifically by decreasing the satiety hormone leptin and increasing the hunger hormone ghrelin, while also impairing glucose metabolism and promoting insulin resistance. Furthermore, experimental studies confirm that restricted sleep leads to increased caloric intake, predominantly from snacks consumed during extended evening hours, resulting in a positive energy balance that favors fat storage. The episode concludes that because the relationship between sleep and obesity is bidirectional, addressing sleep health represents a crucial and modifiable public health strategy for managing metabolic risk.The sources:Sanjay R Patel and Frank B Hu. Short sleep duration and weight gain: a systematic review. Obesity, 16(3):643–653, 2008. doi:10.1038/oby.2007.118.Shahrad Taheri, Ling Lin, Diane Austin, Terry Young, and Emmanuel Mignot. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Medicine, 1(3):e62, 2004. doi:10.1371/journal.pmed.0010062.Karine Spiegel, Esra Tasali, Plamen Penev, and Eve Van Cauter. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Annals of Internal Medicine, 141(11):846–850, 2004. doi:10.7326/0003-4819-141- 11- 200412070-00008.Esra Tasali, Rachel Leproult, and Karine Spiegel. Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Progress in Cardiovascular Diseases, 51(5):381–391, 2009. doi:10.1016/j.pcad.2008.10.002.Arlet V Nedeltcheva, Jennifer M Kilkus, Jacqueline Imperial, Kristen Kasza, Dale A Schoeller, and Plamen D Penev. Sleep curtailment is accompanied by increased intake of calories from snacks. American Journal of Clinical Nutrition, 89:126–133, 2009. doi:10.3945/ajcn.2008.26574.